Nilofer S. Azad

30.9k citations
212 papers · 6.6k · 3 hit papers · h-index 42

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • PARP inhibition in cancer therapy
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Immunotherapy and Biomarkers 38
    • Colorectal Cancer Treatments and Studies 34
    • Pancreatic and Hepatic Oncology Research 31
    • Colorectal Cancer Surgical Treatments 14
    • Epigenetics and DNA Methylation 16

Nilofer S. Azad

200 papers receiving 6.5k citations

Nilofer S. Azad's Hit Papers

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study 2021 · 263 citations
2630+3+7Years since publication100200300400

Peers

Nilofer S. Azad
Comparison fields: 5 of 123
  • Oncology 3.3k
  • Cancer Research 1.0k
  • Hepatology 330
  • Pathology and Forensic Medicine 694
  • Pulmonary and Respiratory Medicine 1.0k
Replace Michael J. Pishvaian with:
Michael J. Pishvaian United States
Elena Élez Spain
Shivaani Kummar United States
Helen X. Chen United States
Kyung-Hun Lee South Korea
Lori J. Wirth United States
Vassilis Georgoulias Greece
Teresa Macarulla Spain
Jennifer J. Wheler United States
Filippo Pietrantonio Italy
Nilofer S. Azad relative to Michael J. Pishvaian United States Michael J. Pishvaian's profile →
Citations per field
00.5×1.5×2.1×
Michael J. Pishvaian · 1×
Citations per year

Countries citing papers authored by Nilofer S. Azad

Since Specialization
Citations

This map shows the geographic impact of Nilofer S. Azad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilofer S. Azad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilofer S. Azad more than expected).

Fields of papers citing papers by Nilofer S. Azad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilofer S. Azad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilofer S. Azad. The network helps show where Nilofer S. Azad may publish in the future.

Co-authors

The 25 scholars most cited alongside Nilofer S. Azad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nilofer S. Azad Line = papers co-authored together Nilofer S. Azad links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Hit paper breakdown →
2019402
2
PD-1 blockade in tumors with mismatch repair deficiency.
Hit paper breakdown →
2015345
3 2014336
4 2013281
5 2008276
6
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Hit paper breakdown →
2021263
7 2019187
8 2018177
9 2020175
10 2020173
11 2014154
12 2014151
13 2013146
14 2019145
15 2019140
16 2016129
17 2009120
18 2009106
19 201685
20 201776

About Nilofer S. Azad

Nilofer S. Azad is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 212 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (38 papers), Colorectal Cancer Treatments and Studies (34 papers), Cancer Genomics and Diagnostics (33 papers), Pancreatic and Hepatic Oncology Research (31 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Genetic factors in colorectal cancer (22 papers), Epigenetics and DNA Methylation (16 papers) and Colorectal Cancer Surgical Treatments (14 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.0k citations), Hepatology (330 citations), Pathology and Forensic Medicine (694 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Nilofer S. Azad has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Elizabeth M. Jaffee, Stephen B. Baylin, Daniel A. Laheru, Cynthia A. Zahnow, Mark Yarchoan, Elise C. Kohn, Charles M. Rudin, Luis A. Díaz, Christina M. Annunziata and Eric S. Christenson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact